Clinical Trials Directory

Trials / Completed

CompletedNCT03066570

Graded Exposure in Patients With Painful Diabetic Neuropathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Objective: To investigate the effects of a cognitive behavioural intervention targeting specific fears in patients with painful diabetic neuropathy, on physical activity and quality of life.

Detailed description

Intervention: Graded Exposure in vivo (GEXP) is a second-generation cognitive-behavioural intervention, and is characterized by systematic and repeated exposure to feared movements, activities and/or sensations in order to decrease fear and subsequently increase physical activity. Main study parameters/endpoints: The purpose of this project is to develop and test a cognitive behavioural intervention targeting specific fears in patients with PDN, in order to increase physical activity and improve QOL.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGraded ExposureGraded Exposure in vivo (GEXP) is a second-generation cognitive-behavioural intervention, and is characterized by systematic and repeated exposure to feared movements, activities and/or sensations in order to decrease fear and subsequently increase physical activity.

Timeline

Start date
2017-06-01
Primary completion
2019-03-18
Completion
2019-03-18
First posted
2017-02-28
Last updated
2020-12-03

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03066570. Inclusion in this directory is not an endorsement.